Long-term stability of soluble ST2 in frozen plasma samples

Clinical Biochemistry

Volumn 43, Issue 13-14, 2010, Pages 1169-1170

  Dieplinger, Benjamin ^a   Egger, Margot ^a   Poelz, Werner ^a   Haltmayer, Meinhard ^a   Mueller, Thomas ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Analyte stability; Biomarker; Heart disease; Inflammation; Interleukin 1 receptor family; Interleukin 33; Soluble ST2

Indexed keywords

BIOLOGICAL MARKER; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 33; SOLUBLE ST2; UNCLASSIFIED DRUG;

ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; FREEZING; HEART DISEASE; HUMAN; MEASUREMENT; PLASMA; PRIORITY JOURNAL; SOLUBILITY;

BLOOD PRESERVATION; CRYOPRESERVATION; EDETIC ACID; HUMANS; PLASMA; PROTEIN STABILITY; RECEPTORS, CELL SURFACE; TEMPERATURE;

EID: 77956171747     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2010.05.019     Document Type: Article

References (4)

1. Kakkar R., Lee R.T. The IL-33/ST2 pathway: therapeutic target and novel biomarker. Nat. Rev. Drug Discov. 2008, 7:827-840.
2. Liew F.Y., Pitman N.I., McInnes I.B. Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat. Rev. Immunol. 2010, 10:103-110.
3. Weinberg E.O. ST2 protein in heart disease: from discovery to mechanisms and prognostic value. Biomarkers Med. 2009, 3:495-511.
4. Dieplinger B., Januzzi J.L., Steinmair M., et al. Analytical and clinical evaluation of a novel high-sensitivity assay for measurement of soluble ST2 in human plasma-the Presage ST2 assay. Clin. Chim. Acta 2009, 409:33-40.